Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, $0.001 Par Value · CUSIP: 252828108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Capital, LP

    Shares: 0.00 · Class: 0%

  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 0.00 · Class: 0%

  • David Kroin

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-004823
Form type
SCHEDULE 13G/A
Filer
Deep Track Capital, LP
CIK
CIK 1856083
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub